<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02664246</url>
  </required_header>
  <id_info>
    <org_study_id>16qqy</org_study_id>
    <nct_id>NCT02664246</nct_id>
  </id_info>
  <brief_title>Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method</brief_title>
  <official_title>Chinese People's Liberation Army General Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This review article have included about ten thousand patients undergoing percutaneous
      coronary intervention (PCI), aim to identify the incidence of CIN in actual, find some new
      risk factors and the protecting methods for these factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About ten thousand patients undergoing percutaneous coronary intervention (PCI) from 2010 to
      2015 are included in this study. We collect the data about the SCr of the patients before and
      after percutaneous coronary intervention, and define CIN as an increase in SCr of 0.5 mg/dl
      or 25% from baseline between 48 and 72 h after contrast medium exposure. Besides we obtain
      the data including clinical characteristics, laboratory data (blood and urine tests) for all
      the patients. The statistical analysis will find some new risk factors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Contrast induced nephropathy postoperation</measure>
    <time_frame>7 days</time_frame>
    <description>peak serum creatinine increase of either 0.5 mg/dl or 25% from day 0 through day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite measure of dialysis or main cardiovascular events</measure>
    <time_frame>90 days</time_frame>
    <description>dialysis, myocardial infarction, heart failure and all-cause death</description>
  </secondary_outcome>
  <enrollment type="Actual">10000</enrollment>
  <condition>Cardio-Renal Syndrome</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>percutaneous coronary intervention</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing percutaneous coronary intervention (PCI) from 2010 to 2015
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. congestive heart failure: objective evidences for decreased left ventricular eject
             fraction (LVEF) &lt;= 50%;

          2. moderate to severe chronic kidney disease was defined as an eGFR 15 to 59 mL/min per
             1.73 m2, calculated via the abbreviated Modification of Diet in Renal Disease (MDRD)
             study equation from SCr obtained within 72 hours of enrollment;

          3. patients were scheduled to undergo diagnostic cardiac angiography or percutaneous
             coronary interventions.

        Exclusion Criteria:

          1. hemodialysis-dependent patients;

          2. complicated with severe short-term progressive disease;

          3. Patients &lt; 18 years;

          4. pregnancy;

          5. emergency cardiac catheterisation (eg, primary percutaneous coronary intervention for
             ST-segment elevation myocardial infarction);

          6. exposure to radiographic contrast media within the previous 7 days;

          7. acute decompensated heart failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dai Yun Chen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Tao SM, Wichmann JL, Schoepf UJ, Fuller SR, Lu GM, Zhang LJ. Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol. 2016 Sep;26(9):3310-8. doi: 10.1007/s00330-015-4155-8. Epub 2015 Dec 18. Review.</citation>
    <PMID>26685852</PMID>
  </reference>
  <reference>
    <citation>Wichmann JL, Katzberg RW, Litwin SE, Zwerner PL, De Cecco CN, Vogl TJ, Costello P, Schoepf UJ. Contrast-Induced Nephropathy. Circulation. 2015 Nov 17;132(20):1931-6. doi: 10.1161/CIRCULATIONAHA.115.014672. Review.</citation>
    <PMID>26572669</PMID>
  </reference>
  <reference>
    <citation>Brillet G, Aubry P, Schmidt A, Catella L, Julien L, BÃ©nard S. Hospital Costs Of Contrast-Induced Nephropathy. Value Health. 2015 Nov;18(7):A510. doi: 10.1016/j.jval.2015.09.1467. Epub 2015 Oct 20.</citation>
    <PMID>26532859</PMID>
  </reference>
  <reference>
    <citation>Andreucci M, Faga T, Pisani A, Sabbatini M, Russo D, Michael A. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. ScientificWorldJournal. 2014;2014:823169. doi: 10.1155/2014/823169. Epub 2014 Nov 30. Review.</citation>
    <PMID>25525625</PMID>
  </reference>
  <reference>
    <citation>Qian G, Fu Z, Guo J, Cao F, Chen Y. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients. JACC Cardiovasc Interv. 2016 Jan 11;9(1):89-96. doi: 10.1016/j.jcin.2015.09.026. Epub 2015 Dec 9.</citation>
    <PMID>26685074</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Qian geng</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>contrast-induced nephropathy</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>risk factors</keyword>
  <keyword>incidence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardio-Renal Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

